Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.17%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+1.87%XMRUSDT-0.45%DOGEUSD+69.80%LINKUSD+2.16%XLMUSD-0.56%BCHUSDT-0.25%LTCUSD+68.40%UNIUSD-0.80%TONUSD+79.92%SUIUSD+1.58%HBARUSDT-0.11%TAOUSDT+2.71%AAVEUSD+1.51%ONDOUSDT+1.09%DOTUSDT+1.15%ICPUSDT+1.84%WLDUSDT+2.44%ARBUSDT+2.38%ATOMUSDT+1.98%INJUSDT+4.96%STXUSDT+4.58%PYTHUSDT+3.03%TIAUSDT+3.05%FETUSDT-0.17%SEIUSDT+0.59%JUPUSDT+1.87%GRTUSDT+0.73%OPUSDT+1.55%IOTAUSDT+1.72%POLUSDT-0.05%WIFUSDT+2.36%AXSUSDT+0.01%EOSUSDT+0.68%IMXUSDT+0.09%FARTCOINUSDT+1.22%GALAUSDT+2.69%DYDXUSDT+0.53%ORDIUSDT+2.36%NOTUSDT+1.19%RONINUSDT+1.91%AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.17%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+1.87%XMRUSDT-0.45%DOGEUSD+69.80%LINKUSD+2.16%XLMUSD-0.56%BCHUSDT-0.25%LTCUSD+68.40%UNIUSD-0.80%TONUSD+79.92%SUIUSD+1.58%HBARUSDT-0.11%TAOUSDT+2.71%AAVEUSD+1.51%ONDOUSDT+1.09%DOTUSDT+1.15%ICPUSDT+1.84%WLDUSDT+2.44%ARBUSDT+2.38%ATOMUSDT+1.98%INJUSDT+4.96%STXUSDT+4.58%PYTHUSDT+3.03%TIAUSDT+3.05%FETUSDT-0.17%SEIUSDT+0.59%JUPUSDT+1.87%GRTUSDT+0.73%OPUSDT+1.55%IOTAUSDT+1.72%POLUSDT-0.05%WIFUSDT+2.36%AXSUSDT+0.01%EOSUSDT+0.68%IMXUSDT+0.09%FARTCOINUSDT+1.22%GALAUSDT+2.69%DYDXUSDT+0.53%ORDIUSDT+2.36%NOTUSDT+1.19%RONINUSDT+1.91%
AP

Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ • Healthcare

$21.12
-$0.26 (-1.3%)
Market closed

Last close at November 20, 2026 at 21:00 UTC

Open$21.26
Day Range$21.07 - $21.71
Avg. Volume (3M)3.3M
Market Cap$7.3B
P/E Ratio49.1
52 Week Range
$11.71$22.13

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$862.6M100%
Gross Profitminus cost of goods$334.1M39%
Operating Incomeminus R&D and overhead$95.4M11%

In plain terms: out of every $100 in revenue, Amneal Pharmaceuticals, Inc. currently loses $1.

Fundamentals & Financials

Revenue (TTM)
$3.1B
Net Income (TTM)
$147.5M
EPS (TTM)
$0.43
ROA (TTM)
2.8%
Current Ratio
1.87
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+58.8%Q2 2026$0.27
+34.8%Q3 2026$0.3
+9.5%Q4 2026$0.26

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +9.5%

Amneal Pharmaceuticals topped consensus on both the top and bottom line in the second fiscal quarter of 2026, reported July 30, 2026, with adjusted EPS of $0.30 topping the $0.22 estimate (+35%) and revenue of $796.2 million topping the $768.2 million estimate (+3.6%). Revenue rose ~10% to about $796.2 million (up from roughly $724.5 million a year ago) across its Generics, Specialty, and AvKARE businesses, while profitability showed up in margins with gross margin at 42.0% and operating margin at 18.3%. Gross profit came in at about $334.5 million and operating income was roughly $146.0 million, and net income surged about 157% year over year to around $57.7 million (up from roughly $22.4 million a year ago). Cash generation was weaker in the period, with negative operating cash flow of about $19.3 million. For the next period, consensus calls for EPS of $0.24 on revenue of $814.0 million.

View full earnings history

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) develops, makes, and sells generic and branded medicines in the healthcare sector, with additional distribution of medical supplies and related services. Across its pharmaceutical manufacturing and supply businesses, Amneal generated $3.0 billion of revenue in FY2025.

Name
Amneal Pharmaceuticals, Inc.
CEO
Chirag K. Patel
Industry
Healthcare
Year Founded
2002
Employees
8,700

Today's Snapshot

AI-generated

AMRX closed 1.3% lower at 21.12, while its sector was flat. AMRX closed within 4.6% of its 52-week high of 22.13. Amneal Pharmaceuticals won FDA approval for oxcarbazepine, a seizure medicine.

Trading Volume

Below 10d avg (2.0M)

1.6M

vs S&P 500 Today

Outperforming Market

+2.23%

Updated: November 20, 2026 at 21:12 UTC

Technical Indicators

4 Buy3 Neutral1 Sell
AMRX shows a mild buy orientation with the quote around 21.12 sitting above the 50-, 100- and 200-day averages even as the very short-term 10-period averages slightly exceed the market. Momentum readings are broadly neutral to mildly positive—RSI near midrange, a small positive momentum print, and a modest MACD—while ADX indicates a weak trend and ATR reflects moderate volatility. Volume signals are mixed, with a large OBV figure flagged as a sell signal. Technical takeaway: modest buy bias anchored by longer-term moving-average support amid tepid trend strength.
All signals
  • EMA (5 indicators)$16.75 - $21.24
    Buy
  • RSI (14)53.67
    Neutral
  • Stochastic %K (14, 3, 3)78.56
    Neutral
  • MACD Level (12, 26)0.39
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.